P & T : a Peer-reviewed Journal for Formulary Management
Overview
P & T is a peer-reviewed journal dedicated to formulary management, providing evidence-based insights on drug selection, utilization, and cost-effectiveness. It offers a platform for healthcare professionals to stay updated on the latest research, guidelines, and strategies for optimizing formulary decisions, improving patient outcomes, and managing healthcare costs.
Details
Details
Abbr.
P T
Start
1990
End
2019
Frequency
Monthly
p-ISSN
1052-1372
Country
United States
Language
English
Specialty
Pharmacology
Recent Articles
1.
MacLaren R, Kiser T, Jung R, Fish D
P T
. 2021 Sep;
31(12):716-734.
PMID: 34522075
Objective: In addition to indications for proton pump inhibitors (PPIs) outside the intensive-care unit (ICU), these medications are frequently used to manage nonvariceal upper gastrointestinal (GI) hemorrhage and to prevent...
2.
Onor I, Andonie G, Hoang L, Smith T, Guillory S, Walvekar S, et al.
P T
. 2021 May;
44(12):749-753.
PMID: 33935476
Thrombocytosis is defined as a platelet count greater than 400,000/mcL. We report the case of a patient who developed thrombocytosis after receiving ciprofloxacin and ceftriaxone therapy. A 73-year-old African-American female...
3.
4.
5.
Yi W, Van Wieren Jones E, Hansen B, Vora J
P T
. 2019 Sep;
44(9):554-559.
PMID: 31485151
Self-monitoring of bood glucose alone is not a good predictor of HbA goal attainment. Health plans might benefit from formulary restrictions to provide more cost-effective care, without negatively impacting glycemic...
6.
Funtanilla V, Candidate P, Caliendo T, Hilas O
P T
. 2019 Sep;
44(9):550-553.
PMID: 31485150
Continuous glucose monitoring offers patients with diabetes a new option for monitoring their glucose levels on a regular basis, without the need for perpetual finger-sticks and myriad supplies.
7.
Veltri K, Olsufka W
P T
. 2019 Sep;
44(9):546-548.
PMID: 31485149
The exact mechanism of a tramadol-warfarin interaction has not been fully determined. The authors present a case study that illustrates the risks.
8.
Redell M, Tillotson G
P T
. 2019 Sep;
44(9):542-544.
PMID: 31485148
Carbapenems are a primary treatment for infections from multidrug-resistant bacterial pathogens. To maintain their efficacy and control the emergence of further resistance, breakpoints that correspond to recommended doses with appropriate...
9.
Barlas S
P T
. 2019 Sep;
44(9):539-544.
PMID: 31485147
House Democrats have been loudly proclaiming their intention to pass legislation that would rein in drug-price increases. But when it comes to actually passing significant bills, reality has not matched...
10.
Fovel L, Miller C, Seabury R, Probst L, Horvath L
P T
. 2019 Sep;
44(9):534.
PMID: 31485146
No abstract available.